Skip to main content

Table 2 Key immunization program cost-effectiveness outcomes

From: Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi

Parameters Base case With indirect protection
Effects
 Total number of non-fatal cases averted 619 993
 Total number of deaths averted 17 27
 Total number of cases averted 636 1 020
 Total DALYs averted 430 690
Costs
 Immunization program costs 397 358 397 358
 Total costs averted (households plus health facilities) 79 789 127 938
 Net program costs 317 569 269 420
Cost-effectiveness ratios
 Net cost per death averted 19 212 10 165
 Net cost per case averted 500 264
 Net cost per DALY averted 738 391
Vaccine requirements
 Doses per death averted 6 631 4 136
 Doses per case averted 172 108
GDP thresholds
 Very cost-effective (GDP/capita) 372 372
 Cost-effective (3*GDP/capita) 1116 1116
\